
IndraLab
Statements
(-)-epigallocatechin 3-gallate inhibits CASP1. 5 / 5
|
5
reach
"177 In one study, EGCG resulted in NFkappaB inhibition, which was associated with reduced melanoma cell interleukin-1beta (IL-1beta) secretion, downregulation of the inflammasome component, nuclear localization leucine-rich-repeat protein 1 (NLRP1), and decreased caspase-1 activation."
reach
"In this study, we found that NO treatment resulted in caspase-1 activation and IL-1beta production, while EGCG inhibited the observed NO induced increase in IL-1beta production and caspase-1 activation, suggesting that the caspase-1 pathway is a potential therapeutic target for preventing NO induced ototoxic damage."